Tumor-associated antigen RHAMM

摘要

The invention provides methods for diagnosing cancer including acute myeloid leukemia and chronic myeloid leukemia, based on the identification of certain cancer-associated polypeptides as antigens that elicit immune responses in cancer. The identified antigens can be utilized as markers for diagnosing cancer, and for following the course of treatment of cancer.